Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Capecitabine × Thoracic × Clear all

Phase

Phase 1 8 Phase 2 4 Phase 1/2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 167 Breast 110 Head & Neck 20 Tumor-Agnostic 4 NET 3 Endocrine 3 CNS 2 Thoracic 1 Other solid neoplasm 1 Other neoplasm 1 Gynecologic 1

Conditions

Advanced Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 232 Cisplatin 185 Pemetrexed 158 Paclitaxel 120 Docetaxel 108 pembrolizumab 88 Gemcitabine 72 Etoposide 52 Erlotinib Hydrochloride 51 Radiotherapy 47 durvalumab 41 Vinorelbine 37 Bevacizumab 37 atezolizumab 35 Nivolumab 33 Gefitinib 31 Drug Therapy 30 osimertinib 24 Topotecan 23 130-nm albumin-bound paclitaxel 19 Radiosurgery 18 tislelizumab 17 Ipilimumab 15 Crizotinib 15 Albumin-Bound Paclitaxel 13 aumolertinib 12 Platinum 12 Dexamethasone 12 Surgical Procedures, Operative 11 Injections 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00345059 2016-01-14

DISTAL-2

National Cancer Institute, Naples

Phase 3 Terminated

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡